Association between procedural time and outcome in unsuccessful mechanical thrombectomy for acute ischemic stroke: analysis from the Italian Registry of Endovascular Treatment in Acute Stroke.

Acute stroke Clinical outcome Procedural time Unsuccessful thrombectomy

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 12 03 2024
accepted: 17 05 2024
revised: 07 05 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: aheadofprint

Résumé

We aim to assess the association between procedural time and outcomes in patients in unsuccessful mechanical thrombectomy (MT) for anterior circulation acute stroke. We conducted a cohort study on prospectively collected data from patients with M1 and/or M2 segment of middle cerebral artery occlusion with a thrombolysis in cerebral infarction 0-1 at the end of procedure. Primary outcome was 90-day poor outcome. Secondary outcomes were early neurological deterioration (END), symptomatic intracranial hemorrhage (sICH) according to ECASS II and sICH according to SITS-MOST. Among 852 patients, after comparing characteristics of favourable and poor outcome groups, logistic regression analysis showed age (OR: 1.04; 95%CI: 1.02-1.05; p < 0.001), previous TIA/stroke (OR: 0.23; 95%CI: 0.12-0.74; p = 0.009), M1 occlusion (OR: 1.69; 95%CI: 1.13-2.50; p = 0.01), baseline NIHSS (OR: 1.01; 95%CI: 1.06-1.13; p < 0.001) and procedural time (OR:1.00; 95% CI: 1.00-1.01; p = 0.003) as independent predictors poor outcome at 90 days. Concerning secondary outcomes, logistic regression analysis showed NIHSS (OR:0.96; 95%CI: 0.93-0.99; p = 0.008), general anaesthesia (OR:2.59; 95%CI: 1.52-4.40; p < 0.001), procedural time (OR: 1.00; 95% CI: 1.00-1.01; p = 0.002) and intraprocedural complications (OR: 1.89; 95%CI: 1.02-3.52; p = 0.04) as independent predictors of END. Bridging therapy (OR:2.93; 95%CI: 1.21-7.09; p = 0.017) was associated with sICH per SITS-MOST criteria whereas M1 occlusion (OR: 0.35; 95%CI: 0.18-0.69; p = 0.002), bridging therapy (OR: 2.02; 95%CI: 1.07-3.82; p = 0.03) and intraprocedural complications (OR: 5.55; 95%CI: 2.72-11.31; p < 0.001) were independently associated with sICH per ECASS II criteria. No significant association was found between the number of MT attempts and analyzed outcomes. Regardless of the number of MT attempts and intraprocedural complications, procedural time was associated with poor outcome and END. We suggest a deeper consideration of procedural time when treating anterior circulation occlusions refractory to MT.

Sections du résumé

BACKGROUND BACKGROUND
We aim to assess the association between procedural time and outcomes in patients in unsuccessful mechanical thrombectomy (MT) for anterior circulation acute stroke.
METHODS METHODS
We conducted a cohort study on prospectively collected data from patients with M1 and/or M2 segment of middle cerebral artery occlusion with a thrombolysis in cerebral infarction 0-1 at the end of procedure. Primary outcome was 90-day poor outcome. Secondary outcomes were early neurological deterioration (END), symptomatic intracranial hemorrhage (sICH) according to ECASS II and sICH according to SITS-MOST.
RESULTS RESULTS
Among 852 patients, after comparing characteristics of favourable and poor outcome groups, logistic regression analysis showed age (OR: 1.04; 95%CI: 1.02-1.05; p < 0.001), previous TIA/stroke (OR: 0.23; 95%CI: 0.12-0.74; p = 0.009), M1 occlusion (OR: 1.69; 95%CI: 1.13-2.50; p = 0.01), baseline NIHSS (OR: 1.01; 95%CI: 1.06-1.13; p < 0.001) and procedural time (OR:1.00; 95% CI: 1.00-1.01; p = 0.003) as independent predictors poor outcome at 90 days. Concerning secondary outcomes, logistic regression analysis showed NIHSS (OR:0.96; 95%CI: 0.93-0.99; p = 0.008), general anaesthesia (OR:2.59; 95%CI: 1.52-4.40; p < 0.001), procedural time (OR: 1.00; 95% CI: 1.00-1.01; p = 0.002) and intraprocedural complications (OR: 1.89; 95%CI: 1.02-3.52; p = 0.04) as independent predictors of END. Bridging therapy (OR:2.93; 95%CI: 1.21-7.09; p = 0.017) was associated with sICH per SITS-MOST criteria whereas M1 occlusion (OR: 0.35; 95%CI: 0.18-0.69; p = 0.002), bridging therapy (OR: 2.02; 95%CI: 1.07-3.82; p = 0.03) and intraprocedural complications (OR: 5.55; 95%CI: 2.72-11.31; p < 0.001) were independently associated with sICH per ECASS II criteria. No significant association was found between the number of MT attempts and analyzed outcomes.
CONCLUSIONS CONCLUSIONS
Regardless of the number of MT attempts and intraprocedural complications, procedural time was associated with poor outcome and END. We suggest a deeper consideration of procedural time when treating anterior circulation occlusions refractory to MT.

Identifiants

pubmed: 38836906
doi: 10.1007/s00415-024-12458-2
pii: 10.1007/s00415-024-12458-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministero della Salute
ID : RFPS-2006-1-336562

Informations de copyright

© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Goyal M, Menon BK, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723–1731
doi: 10.1016/S0140-6736(16)00163-X pubmed: 26898852
Flottmann F, Broocks G, Faizy TD, McDonough R, Watermann L, Deb-Chatterji M, Thomalla G, Herzberg M, Nolte CH, Fiehler J, Leischner H, Brekenfeld C, GSR investigators (2021) Factors associated with failure of reperfusion in endovascular therapy for acute ischemic stroke : a multicenter analysis. Clin Neuroradiol 31:197–205
doi: 10.1007/s00062-020-00880-8 pubmed: 32067055
Abdalla RN, Cantrell DR, Shaibani A, Hurley MC, Jahromi BS, Potts MB, Ansari SA (2021) Refractory stroke thrombectomy: prevalence, etiology, and adjunctive treatment in a North American cohort. Am J Neuroradiol 42:1258–1263. https://doi.org/10.3174/ajnr
doi: 10.3174/ajnr pubmed: 33888454 pmcid: 8324258
Flottmann F, van Horn N, Maros ME, Leischner H, Bechstein M, Meyer L, Sauer M, Deb-Chatterji M, Alegiani A, Thomalla G, Fiehler J, Brekenfeld C, GSR investigators (2022) More retrieval attempts are associated with poorer functional outcome after unsuccessful thrombectomy. Clin Neuroradiol 32:361–368. https://doi.org/10.1007/s00062-021-01054-w
doi: 10.1007/s00062-021-01054-w pubmed: 34236443
García-Tornel A, Requena M, Rubiera M, Muchada M, Pagola J, Rodriguez-Luna D, Deck M, Juega J, Rodríguez-Villatoro N, Boned S, Olivé-Gadea M, Tomasello A, Hernández D, Molina CA, Ribo M (2019) When to stop. Stroke 50:1781–1788. https://doi.org/10.1161/STROKEAHA.119.025088
doi: 10.1161/STROKEAHA.119.025088 pubmed: 31177974
Faizy TD, Broocks G, Heit JJ, Kniep H, Flottmann F, Meyer L, Sporns P, Hanning U, Kaesmacher J, Deb-Chatterji M, Vollmuth P, Lansberg MG, Albers GW, Fischer U, Wintermark M, Thomalla G, Fiehler J, Winkelmeier L, German Stroke Registry–Endovascular Treatment Investigators (2023) Association between intravenous thrombolysis and clinical outcomes among patients with ischemic stroke and unsuccessful mechanical reperfusion. JAMA Netw Open 6:e2310213. https://doi.org/10.1001/jamanetworkopen.2023.10213
doi: 10.1001/jamanetworkopen.2023.10213 pubmed: 37126350 pmcid: 10152307
Mangiafico S, Pracucci G, Saia V, Nencini P, Inzitari D, Nappini S, Vallone S, Zini A, Fuschi M, Cerone D, Bergui M, Cerrato P, Gandini R, Sallustio F, Saletti A, De Vito A, Romano DG, Tassi R, Causin F, Baracchini C, Piano M, Motto C, Ciccone A, Gasparotti R, Magoni M, Giorgianni A, De Lodovici M, Cavasin N, Critelli A, Gallucci M, Carolei A, Meloni T, Corso G, Vaudano G, Duc E, Zappoli F, Cavallini A, Padolecchia R, Tassinari T, Longoni M, Salmaggi A, Zampieri P, Bovi P, Puglioli M, Chiti A, Guidetti G, Simonetti L, Procaccianti G, Menozzi R, Scoditti U, Ricciardi F, Pezzella FR, Guarnieri G, Andreone V, Toni D (2015) The Italian Registry of Endovascular Treatment in Acute Stroke: rationale, design and baseline features of patients. Neurol Sci 36:985–993. https://doi.org/10.1007/s10072-014-2053-5
doi: 10.1007/s10072-014-2053-5 pubmed: 25567080
Seners P, Turc G, Oppenheim C, Baron JC (2015) Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry 86:87–94. https://doi.org/10.1136/jnnp-2014-308327
doi: 10.1136/jnnp-2014-308327 pubmed: 24970907
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352:1245–1251. https://doi.org/10.1016/s0140-6736(98)08020-9
doi: 10.1016/s0140-6736(98)08020-9 pubmed: 9788453
Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, Wahlgren N, Ahmed N, SITS Investigators (2012) Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 43:1524–1531. https://doi.org/10.1161/STROKEAHA.111.644815
doi: 10.1161/STROKEAHA.111.644815 pubmed: 22442178
Junck L, Marshall WH (1983) Neurotoxicity of radiological contrast agents. Ann Neurol 13:469–484. https://doi.org/10.1002/ana.410130502
doi: 10.1002/ana.410130502 pubmed: 6347033
Chu YT, Lee KP, Chen CH, Sung PS, Lin YH, Lee CW, Tsai LK, Tang SC, Jeng JS (2020) Contrast-induced encephalopathy after endovascular thrombectomy for acute ischemic stroke. Stroke 51:3756–3759. https://doi.org/10.1161/STROKEAHA.120.031518
doi: 10.1161/STROKEAHA.120.031518 pubmed: 33121385
Spina R, Simon N, Markus R, Muller DW, Kathir K (2017) Contrast-induced encephalopathy following cardiac catheterization. Catheter Cardiovasc Interv 90:257–268. https://doi.org/10.1002/ccd.26871
doi: 10.1002/ccd.26871 pubmed: 27896904
Vigano’ M, Mantero V, Basilico P, Cordano C, Sangalli D, Reganati P, Lunghi A, Rigamonti A, Salmaggi A (2021) Contrast-induced encephalopathy mimicking total anterior circulation stroke: a case report and review of the literature. Neurol Sci 42:1145–1150. https://doi.org/10.1007/s10072-020-04844-1
doi: 10.1007/s10072-020-04844-1 pubmed: 33089478
Lopez-Navarro ER, Delfs C, Jarre A, Sanio V, Greif G, Gutierrez J, Ringelstein EB, Meuth SG, Haensch CA, Ringelstein A, Ringelstein M (2022) Contrast neurotoxicity and its association with symptomatic intracranial hemorrhage after mechanical thrombectomy. Clin Neuroradiol 32:961–969. https://doi.org/10.1007/s00062-022-01152-3
doi: 10.1007/s00062-022-01152-3 pubmed: 35294573
Sallustio F, Motta C, Pizzuto S, Diomedi M, Giordano A, D’Agostino VC, Samà D, Mangiafico S, Saia V, Legramante JM, Konda D, Pampana E, Floris R, Stanzione P, Gandini R, Koch G (2017) CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke. J Neurointerv Surg 9:940–943. https://doi.org/10.1136/neurintsurg-2016-012628
doi: 10.1136/neurintsurg-2016-012628 pubmed: 27663559

Auteurs

Fabrizio Sallustio (F)

Ospedale dei Castelli, Rome, Italy. fabrizio.sallustio@aslroma6.it.
Emergency Department, Neurovascular Therapy Unit, Castels Hospital, Azienda Sanitaria Locale Roma 6, via Nettunense Km 11,500, Ariccia, 00040, Rome, Italy. fabrizio.sallustio@aslroma6.it.

Ettore Nicolini (E)

Ospedale dei Castelli, Rome, Italy.

Valentina Saia (V)

Santa Corona Hospital, Pietra Ligure, Italy.

Giovanni Pracucci (G)

University of Florence, Florence, Italy.

Alfredo Paolo Mascolo (AP)

Policlinico Tor Vergata, Rome, Italy.

Federico Marrama (F)

Policlinico Tor Vergata, Rome, Italy.

Roberto Gandini (R)

Policlinico Tor Vergata, Rome, Italy.

Valerio Da Ros (V)

Policlinico Tor Vergata, Rome, Italy.

Marina Diomedi (M)

Policlinico Tor Vergata, Rome, Italy.

Fana Alemseged (F)

Royal Melbourne Hospital, Melbourne, Australia.

Ilaria Casetta (I)

Neurology Unit, University Hospital Arcispedale S. Anna, Ferrara, Italy.

Enrico Fainardi (E)

Dipartimento di Scienze BiomedicheSperimentali e ClinicheNeuroradiologia, Università degli Studi di Firenze, Ospedale Universitario Careggi, Florence, Italy.

Lucio Castellan (L)

UO Neuroradiologia Ospedale Policlinico San Martino, Genoa, Italy.

Massimo Del Sette (M)

UO Neurologia Ospedale Policlinico San Martino, Genoa, Italy.

Nicola Limbucci (N)

Interventional Neurovascular Unit, Careggi University Hospital, Florence, Italy.

Patrizia Nencini (P)

Neurology Unit, Careggi University Hospital, Florence, Italy.

Mauro Bergui (M)

Dip Neuroscienze, Universitá di Torino, Turin, Italy.

Paolo Cerrato (P)

A.O. Cittá della Salute, Turin, Italy.

Andrea Saletti (A)

Dip Neuroscienze, UO Neuroradiologia, AZOU, Ferrara, Italy.

Alessandro De Vito (A)

Dip Neuroscienze, UO Neurologia, AZOU, Ferrara, Italy.

Samuele Cioni (S)

UOC Neuroradiologia diagnostica e terapeutica, AOU Senese, Siena, Italy.

Rossana Tassi (R)

UOC Stroke Unit, AOU Senese, Siena, Italy.

Luigi Simonetti (L)

IRCCS Istituto di Scienze Neurologiche di Bologna, UOC Neuroradiologia Ospedale Bellaria, Bologna, Italy.

Andrea Zini (A)

Department of Neurology and Stroke Center, IRCCS Istituto di Scienze Neurologiche di Bologna, Maggiore Hospital, Bologna, Italy.

Maria Ruggiero (M)

AUSL Romagna, Cesena, Italy.

Marco Longoni (M)

UO Neurologia e Stroke Unit Cesena-Forlì, AUSL Romagna, Cesena, Italy.

Agostino Tessitore (A)

UOC Neuroradiologia AOU "G. Martino", Messina, Italy.

Ludovica Ferraù (L)

UOSD Stroke Unit AOU "G.Martino", Messina, Italy.

Nicola Cavasin (N)

UO Neuroradiologia Ospedale dell'Angelo, Venice, Italy.

Adriana Critelli (A)

UO Neurologia Ospedale dell'Angelo, Venice, Italy.

Stefano Vallone (S)

UO NeuroradiologiaOspedale Civile di Baggiovara, AOU di Modena, Modena, Italy.

Guido Bigliardi (G)

Neurologia-Stroke Unit, Ospedale Civile di Baggiovara, AOU di Modena, Modena, Italy.

Domenico Sergio Zimatore (DS)

UO Neuroradiologia AOU Consorziale Policlinico Bari, Bari, Italy.

Marco Petruzzellis (M)

UOC Neurologia e Stroke Unit "Puca" AOU Consorziale Policlinico Bari, Bari, Italy.

Andrea Boghi (A)

Neuroradiologia, Ospedale San Giovanni Bosco, Turin, Italy.

Andrea Naldi (A)

Neurology Unit, San Giovanni Bosco Hospital, Turin, Italy.

Alessio Comai (A)

Department of Neuroradiology, Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy.
Teaching Hospital of Paracelsus Medical University (PMU), Salzburg, Austria.

Elisa Dall'Ora (E)

Teaching Hospital of Paracelsus Medical University (PMU), Salzburg, Austria.
Department of Neurology, Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy.

Giuseppina Sanfilippo (G)

Radiologia e Neuroradiologia diagnostica e interventistica, IRCCS Policlinico San Matteo, Pavia, Italy.

Alessandra Persico (A)

UO Neurologia d'Urgenza e Stroke Unit, IRCCS Fondazione Mondino, Pavia, Italy.

Ivan Gallesio (I)

Department of Radiology, Neuroradiological Unit, Azienda Ospedaliera "SS Antonio e Biagio e C. Arrigo", Alessandria, Italy.

Federica Sepe (F)

Stroke Unit, AO "SS Antonio e Biagio e C. Arrigo", Alessandria, Italy.

Roberto Menozzi (R)

Unità Complessa di Neuroradiologia, Azienda Ospedaliero-Universitaria, Parma, Italy.

Alessandro Pezzini (A)

Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Parma, Italy.
Programma Stroke Care, Dipartimento di Emergenza-Urgenza, Azienda Ospedaliero-Universitaria, Parma, Italy.

Michele Besana (M)

U.O NeuroradiologiaDipartimento di Neuroscienze, Presidio Ospedaliero di Cremona, ASST Cremona, Cremona, Italy.

Alessia Giossi (A)

UOC Neurologia e Stroke Unit ASST Cremona, Cremona, Italy.

Antioco Sanna (A)

SC Neuroradiologia Diagnostica e Interventistica, Pietra Ligure, Italy.

Tiziana Tassinari (T)

Neurology and Stroke Unit, S. Corona Hospital, Pietra Ligure, Italy.

Nicola Burdi (N)

UOC Neuroradiologia, Ospedale "SS. Annunziata", Taranto, Italy.

Giovanni Boero (G)

UOC Neurologia, Ospedale "SS. Annunziata", Taranto, Italy.

Raffaele Augelli (R)

Neuroradiology Department, Ospedale di circolo-asst settelaghi, Varese, Italy.

Manuel Cappellari (M)

Stroke Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Mirco Cosottini (M)

UO Neuroradiologia, Pisa, Italy.

Nicola Giannini (N)

Neurological Institute, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Daniele G Romano (DG)

UOSD Interventistica AOU, Salerno, Italy.

Giulia Frauenfelder (G)

UO Neurologia AOU, Salerno, Italy.

Paolo Nunzio Nuzzi (PN)

UO Neuroradiologia Interventistica, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Maria Carmela Spinelli (MC)

Neurologia d'urgenza e stroke unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Adriana Paladini (A)

Department of Neuroradiology, Vito Fazzi Hospital, Lecce, Italy.

Annalisa Rizzo (A)

Department of Neurology, Vito Fazzi Hospital, Lecce, Italy.

Marco Filizzolo (M)

UO Radiologia, A.O.O.R. Villa Sofia-Cervello, Palermo, Italy.

Marina Mannino (M)

UOC Neurologia con Stroke Unit, A.O.O.R. Villa Sofia-Cervello, Palermo, Italy.

Carmine Timpani (C)

UOC di Radiologia Diagnostica e Interventistca p.o. SS. Filippo e Nicola, Avezzano, Italy.

Federica De Santis (F)

UOC Neurologia e Stroke Unit, H SS. Filippo e Nicola, Avezzano, AQ, Italy.

Giuseppe Carità (G)

UOC Neuroradiologia, Osp.Santa Maria Misericordia, Rovigo, Italy.

Monia Russo (M)

UOS Stroke Unit-Ospedale Santa Maria Misericordia, Rovigo, Italy.

Gianluca Galvano (G)

UO Neuroradiologia, ARNAS Garibaldi, Catania, Italy.

Luigi Sicurella (L)

UO Neurologia ARNAS Garibaldi, Catania, Italy.

Salvatore Mangiafico (S)

Interventional Neuroradiology Consultant at IRCCS Neuromed, Pozzilli (IS), and Adjunct Professor of Interventional Neuroradiology at Tor Vergata University, Sapienza University and S. Andrea Hospital, Rome, Italy.

Danilo Toni (D)

Emergency Department Stroke Unit, Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Classifications MeSH